<?xml version="1.0" encoding="UTF-8"?>
<TreatmentNodes>
    <TreatmentNode Type="Root" Label="A3. Telaprevir for treatment-naive patients and prior relapsers without known cirrhosis">
        <TreatmentNode Type="TreatmentStep" Label="PEG-IFN/RBV + Telaprevir" Duration="4" Help="As part of telaprevir-based therapy, the patient begins peginterferon, ribavirin, and telaprevir simultaneously."></TreatmentNode>
        <TreatmentNode Type="DecisionPoint"
            Label="Week 4: HCV RNA detected" Help="At the end of Week 4, the HCV RNA is measured. The Week 4 response determines whether or not to continue treatment.">
            <TreatmentNode Type="Parent" Value="0" Label="No"
                Text="HCV RNA not detected">
                <TreatmentNode Type="TreatmentStep"
                    Label="PEG-IFN/RBV + Telaprevir" Duration="8" Help="The patient continues treatment with peginterferon, ribavirin and telaprevir. Since HCV RNA was not detected, the patient may be eligible for shortening total treatment duration to 24 weeks, but this decision also depends on the week 12 response.">
                </TreatmentNode>
                <TreatmentNode Type="DecisionPoint"
                    Label="Week 12: HCV RNA Detected" Help="At the end of Week 12, the HCV RNA is measured again. At this testing point you are checking whether the HCV RNA is detectable in order to determine treatment duration.">
                    <TreatmentNode Type="Parent" Value="0" Label="No"
                        Text="HCV RNA not detected">
                        <TreatmentNode Type="TreatmentStep"
                            Label="PEG-IFN/RBV" Duration="12" Help="The patient continues treatment with peginterferon and ribavirin. Telaprevir is discontinued, as it is never given longer than 12 weeks. Since HCV RNA was not detected at week 4 and week 12, the patient meets the criteria for shortening total treatment duration to 24 weeks (assuming HCV RNA stays below detection for the rest of the treatment).">
                        </TreatmentNode>
                        <TreatmentNode Type="Stop"
                            Label="Treatment Complete" Help="HCV RNA is measured after treatment is complete and again 24 weeks later. If the patient's HCV RNA remains not detected at the 24-week SVR assessment, he has a sustained virologic response. If it becomes detectable again, the patient has experienced relapse.">
                        </TreatmentNode>
                    </TreatmentNode>
                    <TreatmentNode Type="Parent" Value="1" Label="Yes"
                        Text="HCV RNA detected">
                        <TreatmentNode Type="DecisionPoint"
                            Label="Week 12: HCV RNA &gt; 1,000 IU/ml" Help="Since HCV RNA was detected, at what level?">
                            <TreatmentNode Type="Parent" Value="0"
                                Label="No"
                                Text="HCV RNA &lt;= 1,000 IU/ml">
                                <TreatmentNode Type="TreatmentStep"
                                    Label="PEG-IFN/RBV" Duration="12" Help="The patient continues treatment with peginterferon and ribavirin. Telaprevir is discontinued, as it is never given longer than 12 weeks. Since HCV RNA was detected when it had previously been suppressed, the patient may be breaking through treatment. HCV RNA levels should be repeated to assess for that.">
                                </TreatmentNode>
                                <TreatmentNode Type="DecisionPoint"
                                    Label="Week 24: HCV RNA detected" Help="At the end of Week 24, the HCV RNA is measured again. At this testing point you are checking to make sure the patient is not experiencing virologic failure, which at this point in the treatment (24 weeks in) means HCV RNA should not be detected.">
                                    <TreatmentNode Type="Parent"
                                        Value="0" Label="No"
                                        Text="HCV RNA not detected">
                                        <TreatmentNode
                                            Type="TreatmentStep"
                                            Label="PEG-IFN/RBV"
                                            Duration="24" Help="The patient continues with peginterferon and ribavirin to complete a total treatment duration of 48 weeks. The patient then stops all treatment.">
                                        </TreatmentNode>
                                        <TreatmentNode Type="Stop"
                                            Label="Treatment Complete" Help="HCV RNA is measured after treatment is complete and again 24 weeks later. If the patient's HCV RNA remains not detected at the 24-week SVR assessment, he has a sustained virologic response. If it becomes detectable again, the patient has experienced relapse.">
                                        </TreatmentNode>
                                    </TreatmentNode>
                                    <TreatmentNode Type="Parent"
                                        Value="1" Label="Yes"
                                        Text="HCV RNA detected">
                                        <TreatmentNode Type="Stop"
                                            Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 24, HCV RNA should not be detected. All treatment should be stopped.">
                                        </TreatmentNode>
                                    </TreatmentNode>
                                </TreatmentNode>
                            </TreatmentNode>
                            <TreatmentNode Type="Parent" Value="1"
                                Label="Yes"
                                Text="HCV RNA &gt; 1,000 IU/ml">
                                <TreatmentNode Type="Stop"
                                    Label="Treatment Stopped" Help="The patient has experienced virologic breakthrough. All treatment should be stopped.">
                                </TreatmentNode>
                            </TreatmentNode>
                        </TreatmentNode>
                    </TreatmentNode>
                </TreatmentNode>
            </TreatmentNode>
            <TreatmentNode Type="Parent" Value="0" Label="Yes"
                Text="HCV RNA Detected">
                <TreatmentNode Type="DecisionPoint"
                    Label="Week 4: &gt; 1,000 IU/ml" Help="Since HCV RNA was detected, at what level?">
                    <TreatmentNode Type="Parent" Value="0" Label="No"
                        Text="&lt;= 1,000 IU/ml">
                        <TreatmentNode Type="TreatmentStep"
                            Label="PEG-IFN/RBV + Telaprevir"
                            Duration="8" Help="The patient continues treatment with peginterferon, ribavirin and telaprevir. Since HCV RNA was detected at week 4, the patient does not meet the response-guided therapy criteria for shortening total treatment duration to 24 weeks.">
                        </TreatmentNode>
                        <TreatmentNode Type="DecisionPoint"
                            Label="Week 12: HCV RNA &gt; 1,000 IU/ml" Help="At the end of Week 12, the HCV RNA is measured again. At this testing point you are checking to make sure the patient is not experiencing virologic failure, which at this point in the treatment (12 weeks in) means HCV RNA should be less than 1,000 IU/ml.">
                            <TreatmentNode Type="Parent" Label="No"
                                Value="0"
                                Text="HCV RNA &lt;= 1,000 IU/ml">
                                <TreatmentNode Type="TreatmentStep"
                                    Label="PEG-IFN/RBV" Duration="12" Help="The patient continues treatment with peginterferon and ribavirin. Telaprevir is discontinued, as it is never given longer than 12 weeks.">
                                </TreatmentNode>
                                <TreatmentNode Type="DecisionPoint"
                                    Label="Week 24: HCV RNA Detected" Help="At the end of Week 24, the HCV RNA is measured again. At this testing point you are checking to make sure the patient is not experiencing virologic failure, which at this point in the treatment (24 weeks in) means HCV RNA should not be detected.">
                                    <TreatmentNode Type="Parent"
                                        Value="0" Label="No"
                                        Text="HCV RNA not detected">
                                        <TreatmentNode
                                            Type="TreatmentStep"
                                            Label="PEG-IFN/RBV"
                                            Duration="24" Help="The patient continues with peginterferon and ribavirin to complete a total treatment duration of 48 weeks. The patient then stops all treatment.">
                                        </TreatmentNode>
                                        <TreatmentNode Type="Stop"
                                            Label="Treatment Complete" Help="HCV RNA is measured after treatment is complete and again 24 weeks later. If the patient's HCV RNA remains not detected at the 24-week SVR assessment, he has a sustained virologic response. If it becomes detectable again, the patient has experienced relapse.">
                                        </TreatmentNode>
                                    </TreatmentNode>
                                    <TreatmentNode Type="Parent"
                                        Value="1" Label="Yes"
                                        Text="HCV RNA detected">
                                        <TreatmentNode Type="Stop"
                                            Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 24, HCV RNA should not be detected. All treatment should be stopped.">
                                        </TreatmentNode>
                                    </TreatmentNode>
                                </TreatmentNode>
                            </TreatmentNode>
                            <TreatmentNode Type="Parent" Label="Yes"
                                Value="1"
                                Text="HCV RNA &gt; 1,000 IU/ml">
                                <TreatmentNode Type="Stop"
                                    Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 12, HCV RNA should be suppressed to &lt;=1000 IU/ml. All treatment should be stopped.">
                                </TreatmentNode>
                            </TreatmentNode>
                        </TreatmentNode>
                    </TreatmentNode>
                    <TreatmentNode Type="Parent" Value="1" Label="Yes"
                        Text="&gt; 1,000 IU/ml">
                        <TreatmentNode Type="Stop"
                            Label="Treatment Stopped" Help="The patient has experienced virologic failure. By the end of Week 4, HCV RNA should be suppressed to &lt;=1000 IU/ml. All treatment should be stopped.">
                        </TreatmentNode>
                    </TreatmentNode>
                </TreatmentNode>
            </TreatmentNode>
        </TreatmentNode>
    </TreatmentNode>
</TreatmentNodes>